Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody-Drug Conjugates

Molecular Cancer Therapeutics
Christopher S NeumannPeter D Senter

Abstract

Antibody-drug conjugates (ADCs) are a therapeutic modality that enables the targeted delivery of cytotoxic drugs to cancer cells. Identification of active payloads with unique mechanisms of action is a key aim of research efforts in the field. Herein, we report the development of inhibitors of nicotinamide phosphoribosyltransferase (NAMPT) as a novel payload for ADC technology. NAMPT is a component of a salvage biosynthetic pathway for NAD, and inhibition of this enzyme results in disruption of primary cellular metabolism leading to cell death. Through derivatization of the prototypical NAMPT inhibitor FK-866, we identified potent analogues with chemical functionality that enables the synthesis of hydrophilic enzyme-cleavable drug linkers. The resulting ADCs displayed NAD depletion in both cell-based assays and tumor xenografts. Antitumor efficacy is demonstrated in five mouse xenograft models using ADCs directed to indication-specific antigens. In rat toxicology models, a nonbinding control ADC was tolerated at >10-fold the typical efficacious dose used in xenografts. Moderate, reversible hematologic effects were observed with ADCs in rats, but there was no evidence for the retinal and cardiac toxicities reported for small-mol...Continue Reading

References

May 18, 2006·Bioconjugate Chemistry·Scott C JeffreyPeter D Senter
Jun 20, 2006·Nature Structural & Molecular Biology·Javed A KhanLiang Tong
Jul 11, 2006·Journal of Medicinal Chemistry·Wayne C WiddisonRavi V J Chari
Jul 19, 2013·Journal of Medicinal Chemistry·Xiaozhang ZhengKenneth W Bair
Oct 30, 2013·Journal of Medicinal Chemistry·Mette K ChristensenFredrik Björkling
Jan 10, 2014·Neoplasia : an International Journal for Oncology Research·Thomas O'BrienDeepak Sampath
Mar 29, 2014·Angewandte Chemie·Ravi V J ChariWayne C Widdison
Oct 7, 2014·PloS One·Weiru WangLisa D Belmont
Oct 31, 2014·The Journal of Biological Chemistry·Christopher Del NagroThomas O'Brien
Dec 3, 2014·Pharmaceutical Research·Amrita V Kamath, Suhasini Iyer
Dec 17, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Tanja S ZabkaDinah L Misner
Feb 25, 2015·Pharmacology & Therapeutics·Deepak SampathPeter S Dragovich
Mar 6, 2016·Molecular Cancer Therapeutics·Patrick J BurkeScott C Jeffrey
Mar 31, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yusuke OgitaniToshinori Agatsuma
Mar 18, 2017·Nature Reviews. Drug Discovery·Alain BeckNathalie Corvaïa
Apr 1, 2017·Advances in Therapy·John M Lambert, Charles Q Morris
Jan 26, 2018·Protein Engineering, Design & Selection : PEDS·D SussmanD R Benjamin
Aug 22, 2018·ACS Medicinal Chemistry Letters·Alexei S KarpovCarl Uli Bialucha

❮ Previous
Next ❯

Citations

Jun 2, 2020·Frontiers in Pharmacology·Ubaldina GalliAmbra A Grolla
Aug 14, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sei-Ichi TanumaFumiaki Uchiumi
Dec 9, 2020·Chemical Society Reviews·Stephen J WalshDavid R Spring
Jun 3, 2021·Nutrients·Moustafa S GhanemAlessio Nencioni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.